Ctc Alternative Strategies, Ltd. Insmed Inc Transaction History
Ctc Alternative Strategies, Ltd.
- $62 Billion
- Q3 2025
A detailed history of Ctc Alternative Strategies, Ltd. transactions in Insmed Inc stock. As of the latest transaction made, Ctc Alternative Strategies, Ltd. holds 2,850 shares of INSM stock, worth $550,677. This represents 0.66% of its overall portfolio holdings.
Number of Shares
2,850Holding current value
$550,677% of portfolio
0.66%Shares
1 transactions
Others Institutions Holding INSM
# of Institutions
672Shares Held
209MCall Options Held
3.83MPut Options Held
4.26M-
Jpmorgan Chase & CO New York, NY23MShares$4.45 Billion0.22% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y920.5MShares$3.95 Billion89.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.9MShares$3.85 Billion0.04% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$2.76 Billion0.02% of portfolio
-
Capital International Investors Los Angeles, CA7.55MShares$1.46 Billion0.18% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $26.2B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...